Name | PDZ1 Domain inhibitor peptide |
---|---|
Synonyms |
L-Valine, N-[[(2S,5S,14S)-14-[[(2S)-6-amino-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-1-oxohexyl]amino]-2-(1-hydroxyethyl)-3,8,15-trioxo-1,4,9-triazacyclopentadec-5-yl]carbonyl]-L-alanyl-
N-({(2S,5S,14S)-2-(1-Hydroxyethyl)-3,8,15-trioxo-14-[(L-tyrosyl-L-lysyl)amino]-1,4,9-triazacyclopentadecan-5-yl}carbonyl)-L-alanyl-L-valine |
Description | PDZ1 Domain inhibitor peptide, a cyclic peptide, incorporates a β-Ala lactam side chain linker and targets the PDZ1 domains of the postsynaptic density protein 95 (PSD-95). PDZ1 Domain inhibitor peptide disrupts the GluR6/PSD-95 interaction and is very efficient in competing against the C terminus of GluR6 for the PDZ1 domain[1]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 1304.2±65.0 °C at 760 mmHg |
Molecular Formula | C38H61N9O11 |
Molecular Weight | 819.945 |
Flash Point | 742.5±34.3 °C |
Exact Mass | 819.449036 |
LogP | -2.24 |
Appearance | White lyophilised solid |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.597 |
Storage condition | Desiccate at -20°C |
Water Solubility | Soluble to 1 mg/ml in 5% acetonitrile / H2O and to 4 mg/ml in DMSO |